estradiol HRT
Selected indexed studies
- The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy? (Postgrad Med, 2009) [PMID:19179815]
- HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT. (Climacteric, 2013) [PMID:23848491]
- Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer's Disease? (Int J Mol Sci, 2023) [PMID:36834617]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy? (2009) pubmed
- HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT. (2013) pubmed
- Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer's Disease? (2023) pubmed
- The use of HRT containing transdermal estradiol in women with a personal history of venous or arterial thromboembolism: A consecutive series of 115 cases. (2025) pubmed
- 17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary study. (2003) pubmed
- Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations. (2009) pubmed
- Divergent impacts of estradiol/testosterone reduction on biological aging: optimal HRT window in females recommended. (2026) pubmed
- Clinical outcomes of different 17β-estradiol drug regimens and their impact on endometrial receptivity. (2025) pubmed
- Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations. (2009) pubmed
- Spotlight on estradiol and norgestimate as hormone replacement therapy in postmenopausal women. (2002) pubmed